论文信息 - A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. - 字舞流文

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

E. Thiel | W. Hofmann | C. Scheibenbogen | U. Keilholz | A. Letsch | A. Asemissen | I. Blau | S. Bauer | L. Uharek | A. Busse